banner_hotel_400x2000_mit15jh-best-quality

January 29th to 31st, 2017 
Jugendstilhotel Paxmontana, Flüeli Ranft

 

We are excited to release to you the >>> Winter Conference Agenda.  Over two and half days, we will share with you some of the most cutting-edge information for business licensing professionals on the theme of Healthcare Megatrends.

Meet your friends and colleagues, join us to dine in fine Swiss style and enjoy the good company around the outside fireside. In honour of those that started the Swiss Healthcare (Pharma) Licensing Group, we have invited our founding members to participate in a special panel discussion: “Megatrends – then, now, tomorrow.” It will be followed by our 15th-anniversary celebration on Monday evening.

A must-attend conference for any BD&L Professional!

Don’t miss out on this unique opportunity! To be part of this exciting event and to receive your Early Bird discount, don’t forget to >>> register before the end of November!

Here’s an outline of what’s in store:

Healthcare Megatrends, how do they Impact Business Models and Deal Structures?

Sunday, January 29th
Conference starts at 16.00; pre-conference workshop at 14.00
  • Optional Pre-Conference Workshop: (Limit 30 participants) Monika Naef, Certified Global Negotiator and Partner at Dufour Attorneys. War of Roses – An Agreement Gone Sour. How to Negotiate Your Way Out
  • Winter Conference Opening Keynote: Thomas Szucs, Chairman of the Board, Helsana. Developing New Medicines in a Time of Cost Containment
  • Speaker: Dominique Hotz, Partner, Price Waterhouse Coopers. Healthcare Trends and their Impact on Corporate Transactions
  • Personal Development and Icebreaking Session: Marc Churin, HR Manager, Samsic. Use of Social Media Beyond Business Networking.

Main Topic Streams and Speakers

Monday, January 30th to Tuesday 31st, 2017

Setting the Stage: Demographic and Economic Perspectives

  • Fred Harms, Vice President, European Health Foundation. The Challenge of Chronic Diseases: If we Change Nothing, Nothing Will Change
  • Otto Schwarz, Executive Vice President, COO, Actelion Pharmaceuticals Ltd Some Personal Thoughts on the Future of the Pharmaceutical Industry

Life Sciences Megatrends

  • Eric Rhodes, CEO, ERS Genomics The Future of Gene Editing
  • Germo Gericke, Global Programme Head Oncology, Novartis Pharma.Immuno-Oncology: Where is the next Checkpoint?
  • Nicholas Benedict, Co-Founder & CEO, Allecra Therapeutics.  Who will Research, Develop and Finance New Antibiotics?

The Global(ization) Perspective

  • Rong Hui Gao, Managing Director, G-Med Consulting. The Evolution of China’s Biomedical Industry and it’s Global Impact.
  • Richard Ridinger, CEO, Lonza Group. Growing along the Healthcare Continuum.
  • Robert Sebbag, VP Access to Medicines, Sanofi. How Innovative Drugs will be Made Accessible in Developing Countries.

Information Technology Megatrends

  • Gregg Talbert, Global Head of Strategic Partnering, Roche Partnering. How will “Big Data” Impact Healthcare?
  • TBC. How Digital Approaches Might Change Healthcare Business Models

Conclusion: What’s in it for us?

  • Sharon Finch, CEO, Medius Research.  How will Megatrends Impact Healthcare Deals?
  • Michel Pettigrew, President, Executive Board & COO, Ferring Pharmaceuticals.  Change in Private/Public Partnerships & Impact on Healthcare.

Panel Discussion: Swiss HLG Founding Members. What did Megatrends look like in 2002 and how did they materialize?

For more information visit our Winter Conference Website.